Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment

Histopathology

Volumn 33, Issue 1, 1998, Pages 80-83

  Bardsley, V ^a,b   Cooper, P ^a   Peat, D S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

GnRH agonist; Lymphocytic infiltration; Uterine leiomyoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; GONADORELIN AGONIST; GOSERELIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPHOCYTIC INFILTRATION; MENORRHAGIA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; T LYMPHOCYTE; UTERUS MYOMA;

EID: 0031877819     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00451.x     Document Type: Article

References (7)

1. Lumsden MA, West CP. Thomas E et al. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids. Br. J. Obstet. Gynaecol. 1994: 301; 438-442.
2. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotrophin-releasing hormone analogues. Human Pathol. 1993: 24; 1073-1077.
3. Upadhyaya NB, Doody MC, Googe PB. Histopathological changes in leiomyomata treated with leuprolide acetate. Steril. Fertil. 1990: 54; 811-814.
4. Crow J, Gardner RL, McSweeney G, Shaw RW. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin. Int. J. Gynaecol. Pathol. 1995: 14; 235-242.
5. Gutmann JN, Thornton KL, Diamond MP, Carcangiu ML. Evalulation of leuprolide acetate treatment on histopathology of uterine myomata. Fertil. Steril. 1994; 61; 622-626.
6. Demopoulos RI, Jones KY, Mittal KR, Vamvakas EC. Histology of leiomyomata in patients treated with leuprolide acetate. Int. J. Gynaecol. Pathol. 1997: 16; 131-137.
7. Ferry JA, Harris NL, Scully RE. Uterine leiomyomas with lymphoid infiltration simulating lymphoma. Int. J. Gynaecol. Pathol. 1989: 3; 263-270.